GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹699 Cr | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr |
What is the latest Consolidated Net Profit of GLAND PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹699 Cr |
| Mar2025 | ₹772 Cr |
| Mar2024 | ₹781 Cr |
| Mar2023 | ₹1,212 Cr |
| Mar2022 | ₹997 Cr |
How is Consolidated Net Profit of GLAND PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹699 Cr | -9.57 | |
| Mar2025 | ₹772 Cr | -1.10 | |
| Mar2024 | ₹781 Cr | -35.54 | |
| Mar2023 | ₹1,212 Cr | 21.54 | |
| Mar2022 | ₹997 Cr | - | |
Compare Consolidated Net Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹46,548.2 Cr | -0.8% | 16.2% | 44% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.8% |
16.2% |
44% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses